A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Study Details
Medical Condition
Study Phase
Intervention Type
Date
Participation Requirements
Gender
Age
Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Have a question?
You can ask us questions via online form or phone call.
Call us @: 844 663-3742
| Location | Status | Site Contact Details |
|---|---|---|
Location Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913 | Status Not Available | |
Location Petrus Center for Aesthetic Surgery & Hair Transplantation, Little Rock, Arkansas, 72205 | Status Not Available | |
Location Therapeutics Clinical Research, San Diego, California, 92123 | Status Not Available | |
Location Radiant Research, Inc., Santa Rosa, California, 95405 | Status Not Available | |
Location DeNova Research, Chicago, Illinois, 60611 | Status Not Available | |
Location Heartland Research Associates, LLC, Wichita, Kansas, 67207 | Status Not Available | |
Location Michigan Center for Skin Care Research, Clinton Township, Michigan, 48038 | Status Not Available | |
Location Minnesota Clinical Study Center, Fridley, Minnesota, 55432 | Status Not Available | |
Location University of Minnesota Department of Dermatology Division of Clinical research, Minneapolis, Minnesota, 55455 | Status Not Available | |
Location Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard, Winston-Salem, North Carolina, 27157 | Status Not Available | |
Location Cleveland Clinic, Dept of Dermatology, Cleveland, Ohio, 44195 | Status Not Available | |
Location NW Dermatology and Research Center, Portland, Oregon, 97210 | Status Not Available | |
Location Oregon Medical Research Center, Portland, Oregon, 97223 | Status Not Available | |
Location Penn State Hershey Medical Center Dermatology Research Office, Hershey, Pennsylvania, 17033 | Status Not Available | |
Location Radiant Research, Inc., Greer, South Carolina, 29650 | Status Not Available | |
Location DermResearch, Inc, Austin, Texas, 78759 | Status Not Available | |
Location Suzzane Bruce and Associates P.A., The Center for Skin Research, Katy, Texas, 77494 | Status Not Available | |
Location The Education & Research Foundation, Inc, Lynchburg, Virginia, 24501 | Status Not Available |
This study will evaluate the safety, tolerability and efficacy of the oral administration of setipiprant tablets 1000 mg twice daily (BID) relative to placebo in 18 to 49 years old males with androgenetic alopecia (AGA).
Change From Baseline in Target Area Hair Count (TAHC) at Week 24
Time Frame: Baseline (Day 1) to Week 24
Subject Self-Assessment (SSA) Score in Hair Growth at Week 24
Time Frame: Week 24
- Not Available
Interventions:
- Drug: Setipiprant
- Drug: Placebo
- Drug: Finasteride
Enrollment:
169
Additional Information
Watch a video to learn more about what you may experience as a clinical trial volunteer: /resources/what-happens-in-a-clinical-trial
Take a virtual reality screening visit tour to an example of a clinical trial site: /resources/screening-visit-virtual-tour
Use a questionnaire tool to think through questions to ask yourself about participating in a clinical trial and print out your responses to discuss with your partners in your health journey: /resource-information-clinical-trial-community/decision-counselor